Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Colorectal Neoplasms: early-phase trial registry
23 of 55 indexed Colorectal Neoplasms trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #254 of 28,707 conditions by registered trial count.
55 US clinical trials · 23 currently recruiting · #254 of 28,707 conditions by registered trial count
Colorectal Neoplasms: 55 US clinical trials tracked, 23 recruiting.
Colorectal Neoplasms is the subject of 55 registered US clinical trials on ClinicalTrials.gov, 23 of them currently open to new participants. 9 are in Phase 3-4 (later-stage) and 31 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 7 of these trials.
Enrollment posture brief
Registry condition colorectal-neoplasms
OPEN 23 | RECR 42% | LATE 9 | EARLY 31 | RANK #254 | SPON 7
Volume-matched condition peers
Nearest open-share peer: Stress (42% recruiting · 153 trials)
Colorectal Neoplasms lists 23 open slots (42% of 55 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Colorectal Neoplasms on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Colorectal Neoplasms is recruiting above its size-band peers.
23 of 55 indexed trials (41.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Colorectal Neoplasms trials is spread across many organizations.
National Cancer Institute (NCI) accounts for 7 of 55 trials (12.7%). 30 distinct sponsors appear on at least one study for this condition label.
-
Typical Colorectal Neoplasms enrolment sits around 268 participants.
Median target enrolment is 268 among the 55 trials that report a genuine target (sentinel values excluded). 16 of those (29.1%) plan for fewer than 100 participants.
-
Colorectal Neoplasms research is mostly interventional.
48 interventional and 7 observational studies make up this index (87.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
55 total, page 2 of 2
Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors
Pfizer
NCT00599924
Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC)
US Oncology Research
NCT01909362
A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...
National Cancer Institute (NCI)
NCT00923481
A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer
Edward Chu, MD
NCT00730158
An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer
Epimmune
NCT00054912
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 8 |
| Phase 3 | 8 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Colorectal Neoplasms records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Colorectal Neoplasms trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Colorectal Neoplasms page
55 registered trials, 23 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 23 Colorectal Neoplasms trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Cancer Institute (NCI) sponsors the most Colorectal Neoplasms trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colorectal Neoplasms condition card totals 55 registered trials; most-linked intervention bevacizumab; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.